News
Zacks.com on MSN39m
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?OptimizeRx posts 11% Q1 growth and rising EBITDA, but long-term momentum hinges on scaling subscriptions and margin mix gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback